FMS

Fresenius Care
NYSE

实时行情|Nasdaq Last Sale

41.01
-1.01
-2.40%
盘后: 41.01 0 0.00% 16:00 02/21 EST
开盘
41.26
昨收
42.02
最高
41.35
最低
40.85
成交量
20.56万
成交额
--
52周最高
42.75
52周最低
31.63
市值
246.42亿
市盈率(TTM)
17.89
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测FMS价格均价为44.47,最高价位49.90,最低价为40.22。

EPS

FMS 新闻

更多
  • CFRA Upgrades Fresenius Medical Care to Buy, Raises Price Target to $46
  • Benzinga · 10小时前
  • Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y
  • Zacks · 11小时前
  • Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 1天前
  • FMC sees U.S. government easing home dialysis goals
  • Reuters · 1天前

所属板块

医疗设施与服务
-0.53%
医疗保健提供商与服务
-0.43%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

FMS 简况

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
展开

微牛提供Fresenius Medical Care AG & Co. KGaA(NYSE-FMS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的FMS股票新闻,以帮助您做出投资决策。